Sechenov School
Home › Pathology › Pulmonary Hypertension

Pulmonary Hypertension

Hypertensio pulmonalis

For medical students2 min readUpdated 2026-10-10

Pulmonary hypertension is a severe pathological syndrome characterized by a sustained increase in blood pressure within the pulmonary circulation. The predictable outcome of this process is right ventricular hypertrophy, subsequently leading to the development of cor pulmonale.

ComplicationLeads to right ventricular hypertrophy and the development of cor pulmonale
MorphologyManifests as plexogenic arteriopathy, pneumosclerosis, and hemosiderosis
GeneticsPrimary form is classified as a polygenic pathology with potential familial inheritance
At-Risk GroupThe primary syndrome more frequently affects children and women aged 20 to 40 years

Role in Pulmonary Vascular Pathology

Pulmonary vascular pathology accompanies a wide variety of diseases and includes several leading syndromes. In addition to pulmonary hypertension, this group includes pulmonary edema, acute respiratory distress syndrome (ARDS), and pulmonary embolism (PE). Hypertension itself is traditionally divided into two major categories: primary (idiopathic) and secondary, which develops against the background of pre-existing conditions. Regardless of the form, the key hemodynamic consequence is the overload of the right heart chambers.

Primary Pulmonary Hypertension Syndrome

The primary form is extremely rare in clinical practice. The main risk group includes children and women aged 20 to 40 years. Although the exact etiology remains unestablished, pathogenesis is associated with several probable factors:

Morphological Features of the Primary Form

Macroscopic and microscopic changes strictly depend on the caliber of the affected vessels. Marked atherosclerosis develops in the large branches of the pulmonary artery. Simultaneously, medium- and small-caliber branches undergo fibrosis and significant muscular hypertrophy.

At the microscopic level, a specific symptom complex known as plexogenic pulmonary arteriopathy develops. The spectrum of these morphological changes strictly corresponds to the stages of disease progression:

  1. The process begins with muscularization of the pulmonary artery wall.
  2. Migration of dark muscle cells directly into the vascular intima occurs.
  3. Intimal cells actively proliferate and transform into myofibroblasts.
  4. Characteristic plexogenic structures are formed.
  5. Vessel walls undergo dilation, inevitably leading to the formation of microaneurysms.
  6. At the final stages, microaneurysms rupture, and fibrinoid necrosis develops in the tissue.

Secondary Pulmonary Hypertension Syndrome

The secondary form is always a complication of other pathological processes. Chronic lung diseases, chronic left ventricular heart failure, and repeated episodes of pulmonary embolism (PE) play a leading role in classical etiology. However, in recent years, the connection between secondary hypertension and the dynamics of chronic liver diseases and chronic viral infections has become increasingly relevant.

Morphological changes in lung tissue in secondary syndrome involve the development of pneumosclerosis—the pathological proliferation of connective tissue. Furthermore, if the disease is accompanied by venous congestion, pulmonary vasculitis, or embolism, hemosiderosis (deposition of an iron-containing pigment) joins the morphological picture.

Mnemonic

To quickly recall the factors driving primary pulmonary hypertension, use the abbreviation AHGF: Autoimmune reactions, Hormonal background, Genetics, Familial/congenital malformations (or Congenital factors).

Frequently asked questions

What mean pulmonary arterial pressure values at rest define pulmonary hypertension?

Pulmonary hypertension is defined by a mean pulmonary arterial pressure of ≥ 25 mmHg at rest. Normally, this value is ≤ 20 mmHg. Depending on other hemodynamic parameters, the following variants are distinguished:

  • Pre-capillary pulmonary hypertension — mean pressure ≥ 25 mmHg, pulmonary capillary wedge pressure ≤ 15 mmHg, pulmonary vascular resistance ≥ 3 Wood units.
  • Post-capillary pulmonary hypertension — mean pressure ≥ 25 mmHg, pulmonary capillary wedge pressure > 15 mmHg.
What specific gene mutations are associated with familial primary pulmonary hypertension?

Mutations in the BMPR2 gene and other candidate genes are associated with hereditary pulmonary arterial hypertension. Sources also indicate that familial cases can be inherited in an dominant or recessive manner, and the disease is classified as a polygenic pathology.

What groups of drugs are used for targeted therapy of pulmonary hypertension?

Specific therapy for pulmonary arterial hypertension includes endothelin receptor antagonists and calcium channel blockers. The mechanism of action of these drugs aims to reduce pulmonary vascular resistance, thereby improving filling of the left heart chambers.

  • Endothelin receptor antagonists — include ambrisentan, bosentan, macitentan, and tezosentan.
  • Calcium channel blockers — used in patients with a long-term response to this drug class.

Therapy is selected strictly individually, as a curative drug does not currently exist.

What ECG signs indicate the development of cor pulmonale and right ventricular hypertrophy?

The development of cor pulmonale and right ventricular hypertrophy is indicated by right axis deviation and specific changes in chest leads. Diagnosis is possible with significant enlargement of right ventricular muscle mass. Key ECG signs of right ventricular hypertrophy:

  • Increased R wave — in leads V1, V2 > 7 mm.
  • Increased S wave — in leads V5, V6 > 7 mm.
  • Index — sum of RV1 + SV5 (V6) > 11 mm.

Additionally, inverted T waves and ST-segment depression in V1, with ST elevation in V5–V6, are registered. With concomitant right atrial hypertrophy, a tall peaked P wave (height > 2.0–2.5 mm) is detected in leads II, III, aVF.

What is the pathogenetic mechanism of pulmonary hemosiderosis in secondary pulmonary hypertension?

The pathogenetic mechanism of pulmonary hemosiderosis in secondary pulmonary hypertension is based on chronic venous congestion. The process includes the following stages:

  • Hyperemia — engorgement of venous vessels with blood.
  • Diapedesis — escape of erythrocytes from the vascular bed into lung tissue.
  • Pigment formation — phagocytosis of erythrocytes by macrophages with the formation of hemosiderin inside siderophages (siderophages).

SH-ferritin, part of hemosiderin, exerts a vasoparalytic effect, which worsens venous congestion, and a sclerogenic effect, stimulating diffuse proliferation of connective tissue. Macroscopically, the lungs acquire a dense consistency and brown coloration, classified as brown induration of the lungs (induratio fusca pulmonum).

Who is in the primary risk group for primary pulmonary hypertension?

The disease predominantly affects children and women of reproductive age (20 to 40 years). This indirectly confirms the role of hormonal status in pathogenesis.

What is plexogenic pulmonary arteriopathy?

This is a specific cascade of microvascular changes in primary hypertension. It includes arterial muscularization, formation of plexogenic structures, development of microaneurysms, and termination in fibrinoid necrosis.

What changes occur in lung tissue during secondary hypertension?

Pneumosclerosis develops in the lung tissue. If the process occurs against a background of venous congestion, vasculitis, or embolism, hemosiderosis additionally develops.

How does pulmonary hypertension affect the heart?

Sustained increased resistance in the pulmonary circulation forces the right ventricle to work harder. This causes compensatory hypertrophy and the development of cor pulmonale.

Go deeper

More topics in Pathology

Systemic Effects of InflammationImmunological Tolerance: Mechanisms and SignificanceClinical and Morphological Forms of Rheumatic FeverBleeding and HemorrhageMorphology of HypertensionMembranous NephropathyEsophageal CarcinomaPathomorphology of Viral Hepatitis BAnthraxPituitary Gland PathologyBreast CancerDyshormonal and Pathological Conditions of Male Genital OrgansPathology →